ALZ-801
Modify Date: 2025-08-22 00:47:54
ALZ-801 structure
|
Common Name | ALZ-801 | ||
|---|---|---|---|---|
| CAS Number | 1034190-08-3 | Molecular Weight | 238.302 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C8H18N2O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ALZ-801ALZ-801 is an orally available, small-molecule β-amyloid (Aβ) anti-oligomer and aggregation inhibitor, valine-conjugated prodrug of Tramiprosate with substantially improved PK properties and gastrointestinal tolerability compared with the parent compound[1]. ALZ-801 is an advanced and markedly improved clinical candidate for the treatment of Alzheimer’s disease[2]. |
| Name | GHG2B47067 |
|---|---|
| Synonym | More Synonyms |
| Description | ALZ-801 is an orally available, small-molecule β-amyloid (Aβ) anti-oligomer and aggregation inhibitor, valine-conjugated prodrug of Tramiprosate with substantially improved PK properties and gastrointestinal tolerability compared with the parent compound[1]. ALZ-801 is an advanced and markedly improved clinical candidate for the treatment of Alzheimer’s disease[2]. |
|---|---|
| Related Catalog | |
| Target |
β-amyloid[1] |
| References |
| Molecular Formula | C8H18N2O4S |
|---|---|
| Molecular Weight | 238.302 |
| InChIKey | NRZRFNYKMSAZBI-ZETCQYMHSA-N |
| SMILES | CC(C)C(N)C(=O)NCCCS(=O)(=O)O |
| GHG2B47067 |